|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genome-Wide Organization and Expression Profiling of the NAC Transcription Factor Family in Potato (Solanum tuberosum L.)显示文摘 | Anil Kumar Singh Vishal Sharma Awadhesh Kumar Pal Vishal Acharya Paramvir Singh Ahuja | 2013 | DNA Research2013，，4： | 2 |
| 2 | The basic and applied aspects of superoxide dismutase显示文摘 | Amit Bafana Som Dutt Arun Kumar Sanjay Kumar Paramvir S. Ahuja | 2010 | B, Enzymatic2010，，2： | 2 |
| 3 | Supporting digital video in a maganed wireless network显示文摘 | | 1998 | IEEE Com Mag1998，，6： | 1 |
| 4 | Recognition of Handwritten Word:First and Second Order Hidden Markov Model Based Approach显示文摘 | Yanghe Paramvir Bahl | 1989 | Pattern Recognition1989，22，3： | 1 |
| 5 | Campbell the draft genome of ciona intestinalis:insights into chordate and vertebrate origins 显示文摘 | Paramvir D Yutaka S Robert K | 2002 | Science2002，298，5601： | 1 |
| 6 | A case for adapting channel width in wireless networks显示文摘 | Ranveer Chandra Ratul Mahajan Thomas Moscibroda Ramya Raghavendra Paramvir Bahl | 2008 | ACM SIGCOMM Computer Communication Review2008，，4： | 1 |
| 7 | A rate adaptive MAC protocol for multi-hop wireless networks显示文摘 | Gavin Holland Nitin H Vaidya Paramvir Bahl | 2001 | Mobile Computingand Networking2001，，： | 1 |
| 8 | Isolation of genomic DNA from tea and other phenol rich plants 显示文摘 | Tapan Kumar Mondal Harsh P Singh Paramvir Singh Ahuja | 2000 | Journal of Plantation Crops2000，28，1： | 1 |
| 9 | A conebased distributed topology-control algorithm for wireless multi- hop networks 显示文摘 | Li (Ercan) Li Joseph Y Halpern and Paramvir Bah1 | 2005 | IEEE/ACM Transactions on Networking2005，13，1： | 1 |
| 10 | The Case for VM-Based Cloudlets in mobile computing显示文摘 | Mahadev S Paramvir B Rambn C | 2009 | IEEE Pervasive Computing2009，8，4： | 1 |
| 11 | Characterization of dihydroflavonol 4-reductase cDNA in tea [Camellia sinensis (L.) O. Kuntze]显示文摘 | Kashmir Singh Sanjay Kumar Sudesh Kumar Yadav Paramvir Singh Ahuja | 2009 | Plant Biotechnology Reports2009，，1： | 1 |
| 12 | Isolation of genomic DNA from tea and other phenol rich plants显示文摘 | Tapan Kumar Mondal Harsh P Singh Paramvir Singh Ahuja | 2000 | Journal of Plantation Crops2000，28，1： | 1 |
| 13 | Amin Saberi: cell breathing in wireless LANs: algorithms and evaluation 显示文摘 | Paramvir ( Victor ) Bahl Mohammad Taghi Hajiaghayi Kamal Jain | 2007 | IEEE Trans Mob Comput2007，6，2： | 1 |
| 14 | Isolation of genomie DNA from tea and other phenol rich plants 显示文摘 | Tapan Kumar Mondal Harsh P Singh Paramvir Singh Ahuja | 2000 | Journal of Plantation Crops2000，28，1： | 1 |
| 15 | Reconsidering Wireless Systems with Multiple Radios显示文摘 | Paramvir Bahl Atul Adya Jitendra Padhye | 2004 | ACM Computer Communications Review2004，34，5： | 1 |
| 16 | Padmanabhan RADAR:An In一Build-ing RF一Based User Location and Tracking System显示文摘 | Paramvir Bahl Venkata N | | 0，，： | 1 |
| 17 | Reconsidering wireless sy-stems with multiple radios显示文摘 | Paramvir Bahl Atul Adya Jitendra Padhye | 2004 | ACM SIGCOMM Computer Communication R-eview2004，34，5： | 1 |
| 18 | Reconsider-ing wireless systems with multiple radios显示文摘 | PARAMVIR B ATUL A J ITENDRA P | 2004 | Computer Communications Review2004，34，5： | 1 |
| 19 | Individualized therapy for metastatic renal cell carcinoma显示文摘Metastatic Renal Cell Carcinoma(mRCC)is a highly heterogeneous disease that is notoriously difficult to treat successfully.However,the discovery of novel,targeted therapies over the last decade has revolutionized its management.As the therapeutic options continue to evolve,developing a more individualized treatment strategy is of paramount importance.The International mRCC Database Consortium(IMDC)is a prognostic model that is commonly used in trials and clinical settings to risk stratify patients.This allows for optimal therapy selection on a more individual basis.However,the distinct lack of validated predictive biomarkers in mRCC renders it difficult to assess therapy response.An improved understanding of tumor biology and genetics has prompted a shift from cytokine therapy to the use of vascular endothelial growth factor(VEGF)inhibitors,tyrosine kinase Inhibitors,immune checkpoint inhibitors or combination strategies.Studies have identified some putative markers and genetic mutations as potential predictors of therapy response.Early results are promising,and there are many ongoing trials further assessing their suitability for clinical use.This review will evaluate the current treatment landscape and molecular biology of mRCC,with a specific focus on the prognostic and predictive markers available to guide treatment options and further improve patient outcomes. | Bambang T.Atmaja Izabelle Wood Suyanto Suyanto Paramvir Sawhney Agnieszka Michael Hardev Pandha | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 0 |
| 20 | Adjuvant therapy for renal cell carcinoma显示文摘Recent advances in the treatment of metastatic renal cell carcinoma expose a gap in the treatment of less advanced,localized disease.Tyrosine kinase inhibitors,which revolutionized the treatment of metastatic disease,have not provided a similar survival benefit in the adjuvant setting and currently only sunitinib is approved by the Food and Drug Administration for adjuvant treatment in patients with high-risk of recurrence based on S-TRAC disease-free survival data.The advent of immune checkpoint inhibitors has offered a fresh hope in the field of adjuvant treatment after encouraging results are seen with combination of immune checkpoint inhibitors as well as with targeted therapy in the metastatic setting.Several studies are investigating these combinations in the adjuvant setting,and it is hoped that they will bring about a better outcome for a largely unmet need in kidney cancer treatment. | Paramvir Sawhney Suyanto Suyanto Agnieszka Michael Hardev Pandha | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员